Biomet, Inc. Sustainability Profile
Biomet, Inc., a prominent player in the medical device industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1977, the company has established itself as a leader in orthopaedics, offering innovative solutions in joint reconstruction, trauma, and spinal surgery. Biomet's core products, including advanced implants and surgical instruments, are distinguished by their commitment to quality and cutting-edge technology. The company has achieved significant milestones, such as pioneering minimally invasive surgical techniques, which have enhanced patient recovery times. With a strong market position, Biomet is recognised for its dedication to improving patient outcomes and has received numerous accolades for its contributions to the healthcare sector. As a trusted name in orthopaedic solutions, Biomet continues to shape the future of medical innovation.
DitchCarbon Score
How does Biomet, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biomet, Inc.'s score of 43 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Biomet, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of reported figures. The company is a current subsidiary of Zimmer Biomet Holdings, Inc., which may influence its climate commitments and emissions reporting. As part of its corporate family, Biomet, Inc. inherits climate initiatives and targets from Zimmer Biomet Holdings, Inc. However, no specific reduction targets or achievements have been documented for Biomet, Inc. itself. The absence of data suggests that the company may still be in the process of establishing its own emissions reporting framework or climate strategy. In the broader context, Zimmer Biomet Holdings, Inc. has been active in climate-related initiatives, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). These initiatives aim to promote transparency and accountability in corporate climate action, although specific targets or commitments for Biomet, Inc. have not been detailed. Overall, while Biomet, Inc. currently lacks specific emissions data and reduction targets, its affiliation with Zimmer Biomet Holdings, Inc. may provide a pathway for future climate commitments and emissions management strategies.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | 00,000,000 |
| Scope 2 | - | - | - | - | - | - | - | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - |
How Carbon Intensive is Biomet, Inc.'s Industry?
How Carbon Intensive is Biomet, Inc.'s Location?
Biomet, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biomet, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
